Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralymphatic Allergen-specific Immunity as a New Administration Route for Treatment of Pollen-induced Allergic Diseases

NCT02423707 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02423707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02423707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralymphatic Allergen-specific Immunity as a New Administration Route for Treatment of Pollen-induced Allergic Diseases
Lead sponsor
Karolinska Institutet
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2010
Completion date
December 31, 2017
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis